{
  "meta": {
    "title": "OmixAI - AI-Powered Omics Analysis"
  },
  "nav": {
    "services": "Services",
    "resources": "Resources",
    "about": "About Us",
    "contact": "Contact",
    "cta": "Contact Us"
  },
  "hero": {
    "title": "Decoding the true language of life",
    "subtitle": "Transform your biological samples into actionable insights",
    "description": "Advanced AI models for proteomics, genomics, and multi-omics integration",
    "cta": "Contact Us"
  },
  "services": {
    "title": "Our Services",
    "items": [
      {
        "icon": "ðŸ§¬",
        "title": "Proteomics"
      },
      {
        "icon": "ðŸ”¬",
        "title": "Multi-Omics"
      },
      {
        "icon": "ðŸ“Š",
        "title": "Biomarkers"
      },
      {
        "icon": "ðŸ¤–",
        "title": "AI x BI"
      }
    ]
  },
  "testimonials": {
    "title": "What Researchers Say",
    "items": [
      {
        "quote": "OmixAI's machine learning models revealed patterns in our proteomics data we never would have found manually.",
        "author": "Dr. Sarah Chen",
        "institution": "MIT"
      },
      {
        "quote": "The multi-omics integration capabilities are game-changing for precision medicine research.",
        "author": "Dr. Michael Rodriguez",
        "institution": "Stanford University"
      },
      {
        "quote": "OmixAI accelerated our biomarker discovery timeline by months. The AI insights are incredibly accurate.",
        "author": "Dr. Emily Watson",
        "institution": "Harvard Medical School"
      }
    ]
  },
  "howItWorks": {
    "title": "How It Works",
    "steps": [
      {
        "number": "1",
        "title": "Send Samples",
        "description": "Send us your biological samples for analysis"
      },
      {
        "number": "2",
        "title": "AI Analysis",
        "description": "We analyze your samples with advanced AI models"
      },
      {
        "number": "3",
        "title": "Get Insights",
        "description": "Receive actionable biological insights"
      }
    ]
  },
  "footer": {
    "tagline": "Fast, Unbiased, Whole Proteomics"
  },
  "resources": {
    "title": "Resource Center",
    "subtitle": "Everything you need to know about our proteomics services",
    "faq": {
      "title": "Frequently Asked Questions",
      "ordering": {
        "title": "Ordering & Pricing",
        "items": [
          {
            "question": "How do I place an order?",
            "answer": "Contact us at omixai@omixai.com with details about your project. We'll provide a customized quote and sample submission instructions."
          },
          {
            "question": "What is the typical turnaround time?",
            "answer": "Standard proteomics analysis takes 2-4 weeks from sample receipt. Rush services are available upon request."
          },
          {
            "question": "What payment methods do you accept?",
            "answer": "We accept bank transfers, purchase orders from academic institutions, and major credit cards for qualifying orders."
          }
        ]
      },
      "samplePrep": {
        "title": "Sample Preparation",
        "items": [
          {
            "question": "What sample types do you accept?",
            "answer": "We accept cells, tissues, biofluids (plasma, serum, CSF), and protein lysates. Contact us for specific sample type requirements."
          },
          {
            "question": "How much sample material do I need?",
            "answer": "For tissue: 10-20mg, cells: 1-5 million, plasma/serum: 10-50Î¼L. Lower amounts may be possible - please inquire."
          },
          {
            "question": "How should I ship my samples?",
            "answer": "Ship frozen samples on dry ice via overnight courier. We'll provide detailed shipping instructions and materials upon order confirmation."
          },
          {
            "question": "What are the sample quality requirements?",
            "answer": "Samples should be flash-frozen and stored at -80Â°C. Avoid freeze-thaw cycles. We can assess sample quality before proceeding with analysis."
          }
        ]
      },
      "technical": {
        "title": "Technical Details",
        "items": [
          {
            "question": "What mass spectrometry platform do you use?",
            "answer": "We use the Thermo Fisher Orbitrap Astral, providing ultra-high resolution (240,000 FWHM) and sensitivity for deep proteome coverage."
          },
          {
            "question": "How many proteins can you identify?",
            "answer": "We routinely identify 8,000-12,000 proteins in human cell lines and tissues with high confidence (FDR < 1%)."
          },
          {
            "question": "What quantification methods do you offer?",
            "answer": "We support label-free quantification (LFQ), TMT/iTRAQ multiplexing, and SILAC approaches depending on your experimental design."
          },
          {
            "question": "What bioinformatics analysis is included?",
            "answer": "Standard analysis includes protein identification, quantification, statistical testing, GO enrichment, and pathway analysis. Advanced AI-powered analysis is available."
          }
        ]
      }
    }
  },
  "about": {
    "title": "About Us",
    "subtitle": "Leadership Team",
    "team": [
      {
        "name": "Dongmyeong Shin, Ph.D.",
        "title": "CEO",
        "photo": "/photos/shindongmyeong.jpg",
        "education": [
          "2018 ~ 2022     Seoul National University, Electrical and Computer Engineering, Ph.D."
        ],
        "experience": [
          "2025 ~ Present     OmixAI Co., Ltd., CEO",
          "2024 ~ 2025     Radisen Co., Ltd., CEO",
          "2021 ~ 2024     Radisen Co., Ltd., CTO"
        ]
      },
      {
        "name": "Jong-Bae Park, Ph.D.",
        "title": "CTO",
        "photo": "/photos/parkjongbae.png",
        "education": [
          "2002 ~ 2006     Harvard Medical School, Postdoctoral Fellow"
        ],
        "experience": [
          "2025 ~ Present     OmixAI Co., Ltd., CTO",
          "2025 ~ Present     Kyung Hee University College of Medicine, Full Professor",
          "2024 ~ Present     Secretary General, Korean Proteome Society; Board Member, Korean Cancer Association",
          "2019 ~ 2023     Director, Industry-Academic Cooperation Foundation",
          "2018 ~ 2021     Director, Cancer Proteomics Research Center",
          "2018 ~ Present     Member, Cancer Control Planning Committee",
          "2017 ~ 2021     Graduate School Dean, National Cancer Center Graduate School of Cancer Science and Policy",
          "2014 ~ Present     Professor, National Cancer Center Graduate School of Cancer Science and Policy",
          "2006 ~ 2014     Principal Investigator, Rare Cancer Research Branch, National Cancer Center"
        ]
      },
      {
        "name": "Jin-Taek Kim",
        "title": "COO",
        "photo": "/photos/kimjintaek.png",
        "education": [
          "1995 ~ 1998     Kookmin University Graduate School of Law (Commercial Law)"
        ],
        "experience": [
          "2025 ~ Present     OmixAI Co., Ltd., COO",
          "2019 ~ Present     April Bio Co., Ltd., CIO",
          "2024 ~ 2025     Radisen Co., Ltd., COO",
          "2023 ~ 2024     Saerom Oriental Pharmaceutical, CEO",
          "2018 ~ 2019     Castelbajac, Director",
          "2011 ~ 2018     Fashion Group Hyungji Co., Ltd., Planning & Coordination Office Director"
        ]
      },
      {
        "name": "Ki-Baek Park",
        "title": "CFO",
        "photo": "/photos/parkkibaek.jpg",
        "education": [
          "2003 ~ 2007     Fudan University Shanghai (Law)"
        ],
        "experience": [
          "2025 ~ Present     OmixAI Co., Ltd., CFO",
          "2024 ~ 2025     Radisen Co., Ltd., CFO",
          "2020 ~ 2024     ONCOcross Co., Ltd., Business Development Director",
          "2018 ~ 2020     ONCOcross Co., Ltd., CFO",
          "2019 ~ 2021     SMBina, Planning Team Leader",
          "2016 ~ 2018     SM Sino, Technology Investment",
          "2014 ~ 2017     Global Bridge Consulting, Director",
          "2010 ~ 2013     Hong Kong Glo-Med Group, Director",
          "2007 ~ 2010     Hong Kong Shanghai Development Zone Venture Investment"
        ]
      }
    ]
  }
}
